Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Seres Therapeutics
MCRB
$45.6M
| $7.09M | ﹤0.01% |
14,479
+10,863
| +300% | +$6.36M |
|
2977
PUT
Children's Place
PLCE
$54.3M
| $7.09M | ﹤0.01% |
141,500
-9,000
| -6% | -$327K |
|
|
CBPO
2978
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $7.09M | ﹤0.01% |
60,000
-71,800
| -54% | -$8.34M |
|
2979
PUT
Verisk Analytics
VRSK
$23.6B
| $7.08M | ﹤0.01% |
34,100
+17,800
| +109% | +$3.46M |
|
2980
CALL
Ametek
AME
$58.4B
| $7.08M | ﹤0.01% |
58,500
+45,000
| +333% | +$5.07M |
|
2981
First Industrial Realty Trust
FR
$8.33B
| $7.08M | ﹤0.01% |
167,939
-846,360
| -83% | -$35.4M |
|
|
BLDP
2982
CALL
Ballard Power Systems
BLDP
$814M
| $7.07M | ﹤0.01% |
302,200
+280,000
| +1,261% | +$5.16M |
|
2983
eHealth
EHTH
$39.1M
| $7.07M | ﹤0.01% |
100,138
-753,904
| -88% | -$57.3M |
|
2984
PUT
GoDaddy
GDDY
$12B
| $7.07M | ﹤0.01% |
85,200
+22,000
| +35% | +$1.73M |
|
2985
CarMax
KMX
$8.5B
| $7.05M | ﹤0.01% |
74,641
-172,870
| -70% | -$16.2M |
|
|
RSX
2986
PUT
DELISTED
VanEck Russia ETF
RSX
| $7.05M | ﹤0.01% |
291,800
+79,500
| +37% | +$1.79M |
|
2987
PUT
Array Technologies
ARRY
$778M
| $7.04M | ﹤0.01% |
+163,100
| New | +$6.58M |
|
2988
CALL
Shift4
FOUR
$3.58B
| $7.04M | ﹤0.01% |
93,300
+45,700
| +96% | +$2.73M |
|
|
FIRY
2989
CALL
Firy Inc
FIRY
$156M
| $7.03M | ﹤0.01% |
17,580
+12,435
| +242% | +$3.7M |
|
2990
Atea Pharmaceuticals
AVIR
$411M
| $7.03M | ﹤0.01% |
+168,205
| New | +$5.42M |
|
2991
CALL
KeyCorp
KEY
$25B
| $7.02M | ﹤0.01% |
427,800
-4,900
| -1% | -$71.4K |
|
|
HPX
2992
DELISTED
HPX Corp.
HPX
| $7.01M | ﹤0.01% |
+700,000
| New | +$6.87M |
|
2993
iShares Agency Bond ETF
AGZ
$565M
| $7M | ﹤0.01% |
+58,542
| New | +$7.05M |
|
|
BHSEU
2994
DELISTED
Bull Horn Holdings Corp. Unit
BHSEU
| $6.99M | ﹤0.01% |
+614,103
| New | +$6.23M |
|
2995
Transocean
RIG
$6.43B
| $6.98M | ﹤0.01% |
3,020,153
+1,746,196
| +137% | +$2.57M |
|
|
PNT
2996
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $6.98M | ﹤0.01% |
500,159
-655
| -0.1% | -$9.09K |
|
2997
Kforce
KFRC
$1.04B
| $6.97M | ﹤0.01% |
165,619
+34,112
| +26% | +$1.35M |
|
2998
CALL
HF Sinclair
DINO
$16.7B
| $6.97M | ﹤0.01% |
269,600
+25,300
| +10% | +$573K |
|
2999
PUT
Zimmer Biomet
ZBH
$19.2B
| $6.96M | ﹤0.01% |
46,556
-13,596
| -23% | -$1.92M |
|
3000
PUT
Quanta Services
PWR
$103B
| $6.96M | ﹤0.01% |
96,700
+16,900
| +21% | +$1.11M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.